GlobeNewswire by notified

Innofactor Plc: Share Repurchase 1.12.2023

Share



Innofactor Plc Announcement 1.12.2023
Innofactor Plc: Share Repurchase 1.12.2023
In the Helsinki Stock Exchange
Trade date 1.12.2023
Bourse trade Buy
Share IFA1V
Amount 4,600Shares
Average price/ share 1.1500EUR
Total cost 5,290.00EUR
Innofactor Plc now holds a total of 561 829 shares
including the shares repurchased on 1.12.2023
On behalf of Innofactor Plc
Nordea Bank Oyj
Janne Sarvikivi Sami Huttunen
Additional information:
Sami Ensio, CEO
Innofactor Plc
Tel. +358 50 584 2029
sami.ensio@innofactor.com
www.innofactor.com







Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Inside information - BBS-Bioactive Bone Substitutes Plc: Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position21.2.2024 09:30:00 CET | Press release

BBS-Bioactive Bone Substitutes Plc, Company announcement, inside information, 21 February 2024 at 10:30 am EET Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position BBS-Bioactive Bone Substitutes Plc's (“BBS”, “the Company”) has signed the drawdown of the advance of EUR 500.000, pursuant to the terms and conditions of the Financing Agreement between BBS and RiverFort Global Opportunities Pcc Limited (“RiverFort”) signed and announced on September 30th 2021. BBS settles the transaction fee of EUR 45,000 by the transfer of 74,915 treasury shares at the price of EUR 0.6007 per share. The reference price as agreed in the terms and conditions of the original agreement is the average of the daily VWAP for each the five consecutive trading day prior to the date of Advance (the “Reference Price”). Following the drawdown of the advance BBS will issue 416,195 warrants to RiverFort (with 0.8410

Nr. 1/2024 - Finanskalender 2024/202521.2.2024 09:27:27 CET | pressemeddelelse

Nasdaq Copenhagen Nikolaj Plads 6 DK-1067 Copenhagen K København, 21 februar 2024 SELSKABSMEDDELELSE nr. 1/2024 FINANSKALENDER 2024/2025 Selskabets finanskalender for 2024/2025 er fastlagt som følger: 2024: 21.02.2024 Årsrapport 2023 21.03.2024 Ordinær generalforsamling 29.08.2024 Delårsrapport, første halvår 2025: 25.02.2025 Årsrapport 2024 26.03.2025 Ordinær generalforsamling Cemat A/S Frede Clausen Bestyrelsesformand Denne selskabsmeddelelse er udarbejdet på dansk og engelsk. I tvivlstilfælde er den danske udgave gældende. Vedhæftet fil Selskabsmeddelelse nr. 1 - 21.02.2024 - Finanskalender

No. 1/2024 - Financial calendar 2024/202521.2.2024 09:27:27 CET | Press release

Nasdaq Copenhagen Nikolaj Plads 6 DK-1067 Copenhagen K Copenhagen, 21 February 2024 ANNOUNCEMENT no. 1/2024 FINANCIAL CALENDAR 2024/2025 The financial calendar for 2024/2025 has been scheduled as follows: 2024: 21.02.2024 Annual Report 2023 21.03.2024 Annual General Meeting 29.08.2024 Interim Report, H1 2025: 25.02.2025 Annual Report 2024 26.03.2025 Annual General Meeting Cemat A/S Frede Clausen Chairman of the Board This announcement has been prepared in a Danish-language and an English-language version. In case of doubt, the Danish version prevails. Attachment Announcement no. 1 - 21.02.2024 - Financial calendar

Nr. 4 2024 Indkaldelse til generalforsamling21.2.2024 09:00:48 CET | pressemeddelelse

Solar A/S afholder ordinær generalforsamling fredag den 15. marts 2024 kl. 11.00 på adressen Industrivej Vest 43, 6600 Vejen. Generalforsamlingen transmitteres til navnenoterede aktionærer via video-webcast på www.solar.eu. Dagsorden for generalforsamlingen er: 1. Bestyrelsens beretning om selskabets virksomhed i det forløbne regnskabsår. 2. Forelæggelse og godkendelse af årsrapport med revideret årsregnskab Bestyrelsen foreslår, at årsrapporten for 2023 godkendes. 3. Beslutning om anvendelse af overskud i henhold til den godkendte årsrapport Bestyrelsen foreslår dernæst, at der udloddes DKK 219 mio. i udbytte for regnskabsåret 2023, svarende til DKK 30,00 pr. aktie á DKK 100. 4. Vejledende afstemning om godkendelse af vederlagsrapport Vejledende afstemning om den af bestyrelsen udarbejdede vederlagsrapport om aflønning af medlemmerne af bestyrelsen og direktionen i 2023. 5. Godkendelse af bestyrelsens vederlag for det igangværende regnskabsår Bestyrelsen foreslår, at det faste bestyre

No. 4 2024 Notice of general meeting21.2.2024 09:00:48 CET | Press release

The Annual General Meeting of Solar A/S will be held on Friday, 15 March 2024, at 11.00 am, at the address Industrivej Vest 43, 6600 Vejen, Denmark. The general meeting will be broadcast by video webcast at www.solar.eu to shareholders on record in the company’s register of shareholders. The agenda of the general meeting is as follows: 1. The Board of Directors’ report on the company’s activities during the past financial year. 2. Presentation and approval of the annual report with audited financial statements. The Board of Directors proposes that the 2023 annual report be approved. 3. Resolution on the allocation of profits in accordance with the approved annual report. The Board of Directors also proposes that DKK 219m be distributed as dividend for the 2023 financial year, corresponding to DKK 30.00 for each share of DKK 100. 4. Indicative vote on the remuneration report. Indicative vote on the remuneration report prepared by the Board of Directors concerning remuneration of members

HiddenA line styled icon from Orion Icon Library.Eye